Researchers combined a microfluidic technology called the CTC-iChip with digital PCR to potentially improve cancer detection in hepatocellular carcinoma patients.
In PNAS this week: mutation patterns in uterine and ovarian carcinosarcomas, deep genome sequences, and more.
TwoXar will work with Stanford's Asian Liver Center to identify and validate computationally-derived drug candidates that target hepatocellular carcinomas.
In Nucleic Acids Research this week: CHOPCHOP web tool update, human retina transcriptional atlas, and more.
A team of researchers has characterized the mutations commonly found in liver cancer, and suggests that the disease may be genomically heterogeneous.
In PNAS this week: common variants that influence viral load in HIV patients, tumor evolution patterns, and more.
A team of scientists has begun to unravel the mysterious mechanisms behind metastatic organotropism, which has been puzzling scientists for over a century.
The findings also provide new clues about the virus' well-established association with hepatocellular carcinoma.
The signatures involve a panel of genes that help researchers to distinguish between benign and malignant liver tumors and identify histological subtypes
NEW YORK (GenomeWeb) – NetScientific today announced that its portfolio firm Glycotest is collaborating with Oncimmune to investigate combining their technologies for the early detection of liver cancer.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.